We are live on ! Find out more
PVMCV

Polaris Venture Management Co V Portfolio holdings

AUM $14.1M
1-Year Est. Return 121.41%
This Fund
S&P 500
This Quarter Est. Return
+30.25%
1 Year Est. Return
+121.41%
3 Year Est. Return
+281.18%
5 Year Est. Return
+1,023.01%
10 Year Est. Return
–
AUM
$175M
AUM Growth
+$62M
Cap. Flow
+$44.6M
Cap. Flow %
25.42%
Top 10 Hldgs %
99.84%
Holding
11
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
CDLX icon
Cardlytics
CDLX
+$44.6M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 71.07%
2 Communication Services 21.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XFOR icon
1
X4 Pharmaceuticals
XFOR
$370M
$42.8M 24.39%
10,383
– –
CDLX icon
2
Cardlytics
CDLX
$21.8M
$38.6M 21.99%
+263,626
New +$44.6M
KALA icon
3
KALA BIO
KALA
$13M
$29.4M 16.76%
744
– –
FATE icon
4
Fate Therapeutics
FATE
$282M
$24.1M 13.76%
2,473,186
– –
RNAC icon
5
Cartesian Therapeutics
RNAC
$218M
$16.4M 9.33%
53,560
– –
TTOO
6
DELISTED
T2 Biosystems, Inc
TTOO
$12.2M 6.94%
375
– –
ATYR
7
aTyr Pharma
ATYR
$46.8M
$4.84M 2.76%
130,571
– –
TRVN
8
DELISTED
Trevena, Inc.
TRVN
$3.37M 1.92%
3,286
– –
GNCA
9
DELISTED
Genocea Biosciences, Inc.
GNCA
$2.07M 1.18%
246,076
– –
PULM icon
10
Pulmatrix
PULM
$6.17M
$1.42M 0.81%
13,982
– –
DARE icon
11
Dare Bioscience
DARE
$18.1M
$273K 0.16%
27,187
– –

Similar funds

IFC
Intact Financial Corporation Toronto, Ontario, Canada $14M AUM
AG
Ashmore Group London, United Kingdom $16.3M AUM 57.83% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
IR
Invictus RG Hamilton, Bermuda $8.9M AUM 56.32% 1-Year Est. Return
CCM
Copernicus Capital Management San Francisco, California $8.26M AUM 37.91% 1-Year Est. Return
EIP
Edgbaston Investment Partners $20.3M AUM 35.98% 1-Year Est. Return
AAM
Areion Asset Management Hong Kong $7.82M AUM 16% 1-Year Est. Return
OEP
Ocean Endowment Partners Chicago, Illinois $20.6M AUM 27.63% 1-Year Est. Return

Polaris Venture Management Co V's Q1 2018 Portfolio in Review

As of Q1 2018, Polaris Venture Management Co V held 11 positions worth $175M, up 55% from $113M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Polaris Venture Management Co V deployed $44.6M of net new capital in Q1 2018, opening 1 new position. Its largest new stake was Cardlytics: 263,626 shares worth $38.6M.

By sector, the portfolio is most concentrated in Healthcare at 71% of assets, down from 93% a quarter earlier, followed by Communication Services.

  • Polaris Venture Management Co V's largest Q1 2018 buy was Cardlytics: 263,626 shares worth $38.6M.
  • Polaris Venture Management Co V's ten largest holdings make up 100% of its $175M portfolio in Q1 2018.
  • Polaris Venture Management Co V opened 1 new position and closed 0 in Q1 2018.
  • Polaris Venture Management Co V's portfolio value rose 55% quarter-over-quarter to $175M.

Based on Polaris Venture Management Co V's 13F filing for Q1 2018, filed 4 May 2018.